chartexchange

BLUE
bluebird bio, Inc. Common Stock
stockNASDAQ

InactiveMay 30, 2025
4.97USD0.000%(0.00)1,245,197
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
MA, USA
Dec 13, 2024 · 1-for-20 (reverse)
BLUE Profile

we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it's not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.

BLUE Performance
PeriodPriceDateChange